An Individualized Anti-Cancer Vaccine Study in Patients With HCC
Clinical trial NCT01995227 · WITHDRAWN
Trial details
- NCT number
- NCT01995227
- Sponsor
- Mirror Biologics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2018-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.